Description
Zanamivirisanantiviralneuraminidaseinhibitorthatisusedclinicallytotreatinfluenzavirusinfection.ZanamivirmayalsoshowsomeinhibitoryactivityagainstRNAvirusinfectionsaswell.
Zanamivirisanantiviralneuraminidaseinhibitorthatisusedclinicallytotreatinfluenzavirusinfection.ZanamivirmayalsoshowsomeinhibitoryactivityagainstRNAvirusinfectionsaswell.
| CasNo. | 139110-80-8 |
|---|---|
| Purity | ≥98% |
| Formula | C12H20N4O7 |
| FormulaWt. | 332.31 |
| IUPACName | (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylicacid |
| Synonym | 5-acetamido-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylicacid |
| Appearance | Whitetooffwhitepowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | Z0252InfoSheetPDF |
|---|
KimJH,ResendeR,WennekesT,etal.Mechanism-basedcovalentneuraminidaseinhibitorswithbroad-spectruminfluenzaantiviralactivity.Science.2013Apr5;340(6128):71-5.PMID:23429702.
LeyssenP,DeClercqE,NeytsJ.MolecularstrategiestoinhibitthereplicationofRNAviruses.AntiviralRes.2008Apr;78(1):9-25.PMID:18313769.